Optimization of self-microemulsifying drug delivery system for telmisartan using Box–Behnken design and desirability function

Authors:

Abstract
Objectives: To develop and optimize the novel self-microemulsifying drug delivery system (SMEDDS) formulation for enhanced water solubility and bioavailability of telmisartan (TMS) using the Box–Behnken design (BBD) and desirability function. Method: TMS-SMEDDS formulation consisted of the mixture of oil (Peceol), surfactant (Labrasol), co-surfactant (Transcutol), TMS and triethanolamine. A three-level BBD was applied to explore the main effect, interaction effect and quadratic effect of three independent variables, including the amount of Peceol (X1), Labrasol (X2) and Transcutol (X3). Determined conditions were 20 < X1 < 40, 50 < X2 < 80 and 5 < X3 < 30. The response variables were droplet size (Y1), polydispersity index (Y2) and dissolution percentage of TMS after 15 min (Y3). Key findings: The optimized conditions were 28.93, 80 and 28.08 (mg) for X1, X2 and X3, respectively, and the response variables were predicted to be 159.8 nm, 0.241 and 85.8% for Y1, Y2 and Y3, respectively. The actual values from the optimized formulation showed good agreement with predicted values. The optimized TMS-SMEDDS formulation showed faster drug dissolution rate and higher bioavailability than TMS powder. Conclusions: Our results suggest that response surface methodology using BBD and desirability function is a promising approach to understand the effect of SMEDDS variables and to optimize the formulation.
Funding Information
  • Ministry of Education, Science and Technology (2012R1A2A2A02044997, 2012R1A1A1039059)

This publication has 23 references indexed in Scilit: